Non-Coding Regulatory Variants in Autoimmune Disease: Biological Mechanisms, Immune Context, and Integrative
Ahmed S A Ali Agha1, Nawras A Al-Zaki1, Saif Aldeen Nasser Alshammari2
1Department of Pharmaceutical Sciences, School of Pharmacy, The University of Jordan, Amman 11942, Jordan.
Biology
|March 13, 2026
Summary
Interpreting genetic risk for autoimmune diseases is challenging. New methods integrating functional genomics and multi-omics reveal that non-coding variants impact specific immune cell states and tissues, aiding disease mechanism understanding.
Area of Science:
- Immunology
- Genetics
- Computational Biology
Background:
- Autoimmune diseases result from complex genetic and immune interactions.
- Most identified genetic risk variants are in non-coding regions with unknown functions.
- Interpreting these non-coding variants is crucial for understanding disease mechanisms.
Purpose of the Study:
- To review analytical frameworks for interpreting non-coding regulatory variants in autoimmune diseases.
- To synthesize emerging methods integrating functional genomics, single-cell, spatial, and multi-omics data.
- To highlight context-dependent effects of genetic variants in specific immune cell states and tissues.
Main Methods:
- Functional genomics
- Single-cell profiling
- Spatial transcriptomics
- Multi-omics data integration
- Massively parallel reporter assays
- Transcriptome-wide association studies
- Single-cell expression quantitative trait locus mapping
Main Results:
- Many autoimmune risk variants have context-dependent effects.
- Effects emerge in specific immune cell states, activation trajectories, or tissue microenvironments.
- Spatial and chromatin-informed technologies clarify regulatory variation's role in immune circuits.
- Machine learning aids molecular endotyping and therapeutic inference.
Conclusions:
- A shift towards dynamic, context-aware analytical frameworks is needed.
- These frameworks enable mechanism-informed interpretation of genetic risk in autoimmune diseases.
- Advances facilitate understanding of genetic contributions to autoimmunity.
Keywords:
autoimmune diseasegenome-wide association studiesimmune regulationmulti-omics integrationnon-coding regulatory variantssingle-cell eQTL mappingspatial transcriptomicsMore Related Videos
09:08Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies
Published on: June 2, 2021
2.1K
04:41Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
Published on: January 9, 2020
19.5K
Related Concept Videos
01:29Autoimmune Disorders
2.1K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
2.1K
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
83
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
83
01:27Principles of Pharmacogenetics: Types of Genetic Variants
70
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
70
01:11Genome-wide Association Studies-GWAS
16.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
16.4K
01:29Pharmacogenomics: Identification of New Drug Targets
61
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
61
02:26Comparing Copy Number Variations and SNPs
19.0K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
19.0K